Canada Life’s Travere Therapeutics TVTX Stock Holding History

Canada Life’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$292K	Hold	9,779	–	–	﹤0.01%	1556
2025 Q4	$374K	Sell	9,779 -13,539	-58%	-$440K	﹤0.01%	1555
2025 Q3	$560K	Hold	23,318	–	–	﹤0.01%	1581
2025 Q2	$346K	Hold	23,318	–	–	﹤0.01%	1660
2025 Q1	$419K	Hold	23,318	–	–	﹤0.01%	1641
2024 Q4	$406K	Buy	23,318 +16,416	+238%	+$290K	﹤0.01%	1674
2024 Q3	$97K	Hold	6,902	–	–	﹤0.01%	1875
2024 Q2	$57K	Hold	6,902	–	–	﹤0.01%	1954
2024 Q1	$53K	Hold	6,902	–	–	﹤0.01%	2010
2023 Q4	$62K	Sell	6,902 -33,272	-83%	-$242K	﹤0.01%	2031
2023 Q3	$359K	Buy	40,174 +8,027	+25%	+$113K	﹤0.01%	1754
2023 Q2	$497K	Buy	32,147 +2,806	+10%	+$51K	﹤0.01%	1688
2023 Q1	$661K	Hold	29,341	–	–	﹤0.01%	1626
2022 Q4	$620K	Buy	29,341 +20,265	+223%	+$429K	﹤0.01%	1661
2022 Q3	$223K	Buy	9,076 +6,344	+232%	+$164K	﹤0.01%	1846
2022 Q2	$66K	Hold	2,732	–	–	﹤0.01%	1998
2022 Q1	$75K	Hold	2,732	–	–	﹤0.01%	2070
2021 Q4	$85K	Sell	2,732 -813	-23%	-$22.9K	﹤0.01%	2042
2021 Q3	$87K	Hold	3,545	–	–	﹤0.01%	2087
2021 Q2	$52K	Hold	3,545	–	–	﹤0.01%	2260
2021 Q1	$88K	Hold	3,545	–	–	﹤0.01%	2137
2020 Q4	$96K	Hold	3,545	–	–	﹤0.01%	2121
2020 Q3	$65K	Hold	3,545	–	–	﹤0.01%	2127
2020 Q2	$72K	Hold	3,545	–	–	﹤0.01%	2132
2020 Q1	$52K	Hold	3,545	–	–	﹤0.01%	2121
2019 Q4	$50K	Buy	+3,545	New	+$45.3K	﹤0.01%	2261
2019 Q3	–	Sell	-3,428	Closed	-$69K	–	2203
2019 Q2	$69K	Sell	3,428 -572	-14%	-$11.3K	﹤0.01%	2343
2019 Q1	$90K	Hold	4,000	–	–	﹤0.01%	2099
2018 Q4	$87K	Hold	4,000	–	–	﹤0.01%	2191
2018 Q3	$115K	Hold	4,000	–	–	﹤0.01%	2149
2018 Q2	$109K	Hold	4,000	–	–	﹤0.01%	2161
2018 Q1	$90K	Hold	4,000	–	–	﹤0.01%	2196
2017 Q4	$84K	Hold	4,000	–	–	﹤0.01%	2216
2017 Q3	$99K	Hold	4,000	–	–	﹤0.01%	2159
2017 Q2	$77K	Hold	4,000	–	–	﹤0.01%	2188
2017 Q1	$74K	Hold	4,000	–	–	﹤0.01%	2200
2016 Q4	$76K	Hold	4,000	–	–	﹤0.01%	2211
2016 Q3	$89K	Hold	4,000	–	–	﹤0.01%	2182
2016 Q2	$71K	Hold	4,000	–	–	﹤0.01%	2217
2016 Q1	$55K	Hold	4,000	–	–	﹤0.01%	2088
2015 Q4	$77K	Hold	4,000	–	–	﹤0.01%	1931
2015 Q3	$81K	Hold	4,000	–	–	﹤0.01%	1844
2015 Q2	$132K	Buy	+4,000	New	+$110K	﹤0.01%	1667

Other funds holding TVTX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Canada Life's TVTX Position: Q1 2026 in Review

Canada Life held its Travere Therapeutics (TVTX) position steady in Q1 2026 at 9,779 shares worth $292K. The position accounts for ﹤0.01% of the portfolio, ranked #1556.

Canada Life first reported a position in TVTX in Q2 2015 and has held it in 43 quarters since. The position peaked at $661K in Q1 2023. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

Canada Life held 9,779 shares of Travere Therapeutics worth $292K as of Q1 2026.
Canada Life left its Travere Therapeutics share count unchanged in Q1 2026.
Travere Therapeutics made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1556 holding.
Canada Life first reported a position in Travere Therapeutics in Q2 2015 and has held it in 43 quarters since.
Canada Life's Travere Therapeutics position peaked at $661K in Q1 2023.
260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.